Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05019430Phase 1Completed
Phase 1, randomised, double-blind trial of zolmitriptan in cocaine use disorder (CUD) (4 arms). Primary endpoint: Reinforcing Effects of Cocaine at 4 hours. Started Oct 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05019430.